Investor Relations
Stock Info

Investor Relations Overview

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF) is a leading provider of advanced medical technologies designed to support the most vulnerable patient populations and improve the standard of care in pediatric and acute care hospitals.

For more than 20 years, we have successfully delivered vascular access, advanced wound care, perioperative care, and customized medical device coating solutions to patients throughout the U.S., Canada, Europe, and the Middle East. Our U.S. pediatric customer base continues to expand with four of the top five pediatric hospitals in the U.S., as ranked by U.S. News & World Report, adopting Covalon’s technology as part of their infection prevention protocols. 

We offer innovative, gentler, and more compassionate options for patients to heal with fewer infections, less pain, and better outcomes because healing shouldn’t hurt.

Press Releases
Nov 21, 2022

A two-year study with the aim of preventing sternal wound infections highlights SurgiClear as a key component of the infection prevention bundle used to significantly reduce infection rates...

Nov 8, 2022

Amongst a climbing Central Line Associated Blood Stream Infection ("CLABSI") rate across the United States, Covalon is releasing new digital resources focused on the role of technology to...

Nov 1, 2022

Evidence on Covalon's New ColActive Plus Powder presented at the Symposium on Advanced Wound Care MISSISSAUGA, ON, Nov. 1, 2022 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon")...

View All